Medical Weight Loss for Kansas City, Kansas Residents

Kansas City, Kansas residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Kansas City through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Start this week from Kansas City: book a video visit, complete your intake, and if you are a fit, your compounded medication ships to your Kansas door. No travel to California required. Doctor review just $119 (medication separate).

Why Kansas City Residents Choose New Hope Weight Loss

At New Hope Weight Loss, every case in Kansas City is overseen by a named physician, Dr. Anjmun Sharma, MD. You are not handed off to a rotating panel of strangers or a faceless intake bot. Dr. Sharma reviews your history, signs off on your plan, and stays accountable for it. That single point of medical responsibility is rare in telehealth, and it is the reason so many people across Kansas trust us to guide a serious decision about their health.

From our Costa Mesa, California practice, we provide Kansas City with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

You do not need a clinic on your street in Kansas City to work with a real physician, because everything Dr. Sharma offers from Costa Mesa reaches patients across Kansas by secure telehealth. We care for patients throughout the greater Wyandotte County area and the Kansas side of metro Kansas City, with bilingual Spanish care. Your plan is shaped around your own history, the medications you have tried, and the goals you bring, not a one-size template applied to every Kansas City patient.

Patients on the outskirts of Kansas get the same flat pricing, the same physician, and the same fast start as those near the center of Kansas City. Please note that our compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical, and results vary from person to person. Across both the urban and rural stretches of Kansas, New Hope Weight Loss cares for patients entirely by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide: the 90-Day Metabolic Reset

If you live in Kansas City and want a clear starting point, this is it. Semaglutide, the active ingredient also used in Wegovy and Ozempic, costs from $166 per month or $499 for the 90-day program. Branded-drug trials showed roughly 15 to 17 percent average weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, so results vary.

Tirzepatide: the dual GLP-1 and GIP option

For patients who want a second lever, tirzepatide starts at $233 per month and acts on both GLP-1 and GIP receptors. Up to 22.5 percent body-weight loss appeared in branded-drug trials at qualifying doses, which is not typical. It shares an active ingredient with Mounjaro and Zepbound.

A $119 physician review is required up front. Medication billed separately. HSA, FSA, Klarna, and Affirm are accepted.

How Telehealth Works for Kansas City

From your first quiz to your last follow-up, the process is built for busy people in Kansas City.

1. Complete a secure online intake about your medical history and weight goals.

2. Dr. Sharma reviews it and meets you over secure video, usually within 48 hours.

3. If a compounded GLP-1 suits you, a state-licensed 503(a) pharmacy ships semaglutide or tirzepatide to your Kansas City home in cold-pack packaging.

4. You continue with video follow-ups, anywhere in , at the cadence your plan calls for.

Frequently Asked Questions, Kansas City

Where is the closest New Hope Weight Loss to Kansas City?

Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because Kansas City, Kansas patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.

Is in-person attendance required for patients from Kansas City?

It is not. We run a complete telehealth model, so people in Kansas City handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. Approved medication is shipped to Kansas City using cold-pack insulation that keeps it stable until it reaches you.

What should a Kansas City patient budget for care?

The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and Kansas City patients are not charged any extra distance fee.

What areas of Kansas City do you serve?

We serve patients from across Kansas City by telehealth, including the greater Wyandotte County area and the Kansas side of metro Kansas City, with bilingual Spanish care.

How does telehealth treatment work for Kansas City patients?

You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Kansas City address. Follow-ups also happen by video.

Kansas City Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Kansas City, Kansas by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.